Philippine Drug Prices Reductions effective August 15 and September 15, 2009

Wednesday, November 11, 2009


Although the recent price reductions mandated for five drugs here in the Philippines have been made it is hard to find a source online that indicates exactly what these prices are but I did find a source finally

Also check out the generic pharmarcies here in the Philippines at my blog

from the Drugstores Association of the Philippines

http://www.dsaph.org/

I am reprinting from their website what they have broken out in clear detail on the prices and dates effective

DATE: AUGUST 10, 2009
TO: ALL DSAP MEMBERS
FROM: NATIONAL AFFAIRS COMMITTEE
RE: IMPLEMENTATION OF MAXIMUM DRUG RETAIL PRICES FOR SELECTED DRUGS AND MEDICINES

OBJECTIVE:

THIS MEMO AIMS TO PROVIDE GUIDELINES TO DSAP MEMBERS ON THE IMPLEMENTATION OF MAXIMUM RETAIL PRICE ON SELECTED MEDICINES AS PROVIDED BY EO 821.

BACKGROUND AND FACTS:

* RA 9502 known as “The Universally Accessible Cheaper and Quality Medicine Act of 2008” provided that price regulation of medicine can be imposed by the

State.
* The President of the Philippines, upon the recommendation of the Secretary of the Department of Health has the power to impose maximum retail prices

over “any all drugs and medicines” included in the list found in the law.
* The list of drugs that can be subjected to the Maximum Drug Retail Price (MDRP) is determined based on the following premises:

1. condition that address public matters such as leading cause of morbidity and mortality;
2. drugs with high price difference compared to international price;
3. drugs that have few competitors in terms of lack of generic counterparts or lack of market access to the product;
4. drugs where innovator product is still the highest priced product, the most prescribed and/or dispensed inspite existence of cheaper versions.

* On July 27, 2009 President Gloria Macapagal Arroyo issued Executive Order 821 imposing price cuts to five (5) molecules and announcing the price

reduction of the sixteen (16) more drugs done voluntarily by the pharmaceutical companies. Price reduction is at least 50%.

* In addition to the above list, the pharmaceutical companies also committed to reduce by about 10-50% the prices of twenty-two (22) other products.

IMPLEMENTATION GUIDELINES

1. The implementation of MDRP shall commence on August 15, 2009 but sanctions shall be imposed only on September 15, 2009.

2. The MDRP shall be imposed on all retail establishments both public and private. These include drugstores, hospital, hospital pharmacies, health maintenance organization (HMOs), convenience stores, supermarkets and the like.

3. The prescribed MDRP shall serve as the ceiling for the retail price of drugs in the list. Ceiling for the reimbursement at PhilHealth.

4. The list for the mandated MDRP as provided by EO 821 is given below:

ACTIVE INGREDIENT/MOLECULEDOSAGE STRENGHT AND FORMMDRP (Php)
ANTI-HYPERTENSIVE
Amlodipine (including its S-isomer and all salt form)2.5 mg tablet9.60
5 mg tablet22.85
10 mg tablet38.50
ANTI-CHOLESTEROL
Atorvastatin10 mg film-coated tablet34.45
20 mg film-coated tablet39.13
40 mg film-coated tablet50.50
80 mg film-coated tablet50.63
Amlodipine besilate 5 mg + Atorvastatin calcium 10 mg tablet45.75
Amlodipine besilate 5 mg + Atorvastatin calcium 20 mg tablet66.25
Amlodipine besilate 5 mg + Atorvastatin calcium 40 mg tablet84.42
Amlodipine besilate 5 mg + Atorvastatin calcium 80 mg tablet89.99
Amlodipine besilate 10 mg + Atorvastatin calcium 10 mg tablet51.13
Amlodipine besilate10 mg + Atorvastatin calcium 20 mg tablet73.25
Amlodipine besilate 10 mg + Atorvastatin calcium 40 mg tablet91.79
Amlodipine besilate 10 mg + Atorvastatin calcium 80 mg tablet91.79
ANTIBIOTIC/ANTIBACTERIAL
Azithromycin and all its Salt Form250 mg tablet108.50
200 mg/5 ml powder for suspension (15 ml)427.50
200 mg/5 ml powder for suspension (22.5 ml)638.00
500 mg tablet151.43
500 mg vial for injection992.50
2 g granules468.00
ANTI-NEOPLASTICS/ ANTI-CANCER
Cytarabine100 mg/ml ampul/vial(IV/SC)240.00
100 mg/ml ampul/vial(IV/SC) (5 ml) or 500 mg vial900.00
100 mg/ml ampul/vial(IV/SC) (10 ml) or 1g vial1800.00
20 mg/ml (5ml) ampul/vial for injection1980.00
Doxorubicin and all its Salt Form10 mg powder vial for injection1465.75
50 mg powder vial for injection2265.74

5. The list under Voluntary Price Reduction scheme as provided by Resolution 2009-001 of the Advisory Council for Price Regulation is as noted in chart at end of this blog

6. Price differentials that shall result from this price reduction shall be shouldered by the corresponding manufacturer, trader or importer.

7. The price differential s shall be reimbursed or rebated to the drugstores by the manufacturers, traders or importers in the manner and procedures they deem appropriate and practical. (Attached herewith is the guidelines issued by Metro Drug Incorporated).

8. Violation of this imposition shall be dealt with penalties as mandated by the IRR of the Cheaper Medicine Bill. Penalties for violation of the MDRP shall be no less than Fifty-thousand pesos (P50,000.00) but not more than five million pesos (P5,000,000.00).

9. The list of medicine subject to MDRP shall be reviewed after three (3) to six (6) months by the DOH and as may be recommended.
DSAP ADVISORY

1. Make inventory of the products found on the list. Try to find their appropriate references such as delivery receipts and invoices.

2. Contact your suppliers and know them their respective reimbursement procedures.

3. If you are sourcing your products from wholesalers, consult with them to find out how they can help you with the reimbursement.

ACTIVE INGREDIENT/MOLECULEDOSAGE STRENGTH AND FORMCOMPANYOLD RETAIL PRICEGOVERNMENT-MEDIATED ACCESS PRICE
ANTI-HYPERTENSIVE
Telmisartan40 mg tabletBoehringer51.5025.7
Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg tabletBoehringer50.0025.00
80 mg tabletBoehringer89.0044.50
Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg tabletBoehringer89.0044.50
Irbesartan150 mg tabletSanofi-Aventis via Winthrop48.7624.38
Irbesartan 150 mg + Hydrochlorothiazide 12.5 mg tabletSanofi-Aventis via Winthrop50.2625.13
300 mg tabletSanofi-Aventis via Winthrop80.0040.00
Irbesartan 300 mg + Hydrochlorothiazide 12.5 mg tabletSanofi-Aventis via Winthrop83.0041.50
ANTI-THROMBOTIC
Clopidogrel75 mg film-coated tabletSanofi – Aventis123.5061.75
ANTI-DIABETIC/ANTIHYPOGLYCEMIC
Gliclazide30 mg Modified Release TabletServier15.007.50
80 mg tabletServier15.007.50
ANTIBIOTIC / ANTIBACTERIAL
Piperacillin +Tazobactam and all its Salt formPiperacillin 2 g + Tazobactam 250 mg vialWyeth2175.46730.20
4 g + Tazobactam 500 mg vialWyeth4614.001270.06
Ciprofloxacin and all its Salt form500 mg tabletBayer83.8341.91
500 mg tablet (Extended Release)Bayer99.2349.62
1 g tabletBayer145.1072.55
250 mg tabletBayer65.1332.57
2mg/ml (100 ml) for injectionBayer1884.17942.00
2 mg/ml (50 ml) or 100 mg IV infusion (50 ml)Bayer1440.87720.43
400 mg (20 ml) for injectionBayer3207.171603.59
Metronidazole and all its Salt form125mg/5 ml (60 ml) suspensionSanofi-Aventis131.0065.50
500 mg tabletSanofi-Aventis via Winthrop23.5011.75
500 mg (100 ml) IV infusionSanofi-Aventis379.50189.75
Co-Amoxiclav

    (Amoxicillin + Clavulanic acid)
625 mg tabletGSK97.7548.90
375 mg tabletGSK79.5039.75
1 g tabletGSK142.2571.15
600 mg vial for injectionGSK687.50343.75
1.2 g vial for injectionGSK1156.75578.40
Amoxicillin 200 mg + Clavulanic Acid 28.5 mg/5ml (70 ml) suspensionGSK555.50277.75
Amoxicillin 125 mg + Clavulanic Acid 31.25 mg/5ml (60 ml) suspensionGSK378.00189.00
Amoxicillin 250 mg + Clavulanic Acid 62.5 mg/5ml (60 ml) suspensionGSK648.50324.25
Amoxicillin 400 mg + Clavulanic Acid 57 mg/5ml (70 ml) suspensionGSK940.50470.25
Amoxicillin 400 mg + Clavulanic Acid 57 mg/5ml (35 ml) suspensionGSK523.75261.90
ANTI-NEOPLASTIC
ANTI-CANCER
Bleomycin and all its Salt form15 mg vial/ampul for injectionBristol-Meyer Squibb via Zuellig9750.003520.00
Carboplatin10 mg/ml (15 ml) vial or 150 mg for injectionBristol-Meyer Squibb via Zuellig3610.001805.00
Cisplatin50 mg powder vial for injectionBristol-Meyer Squibb via Zuellig2804.001125.00
Cyclophosphamide50 mg tabletBristol-Meyer Squibb via Zuellig33.5017.50
200 mg vial for injectionBaxter698.95175.00
500 mg vial for injectionBristol-Meyer Squibb via Zuellig649.00324.50
1 g or 1000 mg vial for injectionQualimed1155.00 (most expensive)577.50
Etoposide (No innovator locally)100 mg tabletQualimed1130.00 (most expensive in the market)565.00
Mercaptopurine50 mg tabletGSK79.0039.50
Methotrexate sodium (No innovator locally)2.5 mg tabletQualimed23.00 (most expensive brand)11.00
50 mg/ 2 ml vial for injectionQualimed612.00 (most expensive brand)306.00
Mesna400 mg ampul for injectionBaxter369.00166.67

JOSEPHINE P. INOCENCIO

National President

0 comments

Post a Comment